Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mahaffey

Showing results (71-80 of 627) with videos related to

Pageof 63
Sort By:
American Heart Journal|June 1, 2002
Safety and efficacy of only 2 weeks of ticlopidine therapy in patients at increased risk of coronary stent thrombosis: results from the Antiplatelet Therapy alone versus Lovenox plus Antiplatelet therapy in patients at increased risk of Stent Thrombosis (ATLAST) trialPeter B Berger, Ken W Mahaffey, Susan J Meier, et al.
American Journal of Nephrology|June 19, 2026
Adjudicating Heart Failure Events in Participants Receiving Hemodialysis: Findings from Evaluation of Cinacalcet Hydrochloride Therapy to Lower Cardiovascular Events (EVOLVE) TrialGuson Kang, Safa Abdalla, Patrick S Parfrey, et al.
Postgraduate Medicine|May 14, 2010
A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetesRobert Frederich, John H Alexander, Fred T Fiedorek, et al.
European Heart Journal|March 20, 2003
Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?A Hersi, Y Fu, B Wong, et al.
The Canadian Journal of Cardiology|April 28, 2006
N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarctionJustin A Ezekowitz, Pierre Théroux, Weiching Chang, et al.
Journal of Thrombosis and Thrombolysis|June 22, 2016
Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarctionSean van Diepen, Wendimagegn G Alemayehu, Yinggan Zheng, et al.
JACC. Cardiovascular Interventions|July 20, 2013
Prognostic significance of bleeding location and severity among patients with acute coronary syndromesJohn P Vavalle, Robert Clare, Karen Chiswell, et al.
American Heart Journal|January 25, 2008
Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapyDerek P Chew, Zhen Huang, Karen S Pieper, et al.
The Journal of Vascular Access|November 28, 2019
A double-blind, randomized, placebo-controlled pilot trial to evaluate safety and efficacy of vorapaxar on arteriovenous fistula maturationChristoph B Olivier, Vandana Sundaram, Glenn M Chertow, et al.
The American Journal of Cardiology|March 15, 1996
Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapyK W Mahaffey, C B Granger, R Collins, et al.
Pageof 63

Showing results (71-80 of 627) with videos related to

Sort By:
Pageof 63
American Heart Journal|June 1, 2002
Safety and efficacy of only 2 weeks of ticlopidine therapy in patients at increased risk of coronary stent thrombosis: results from the Antiplatelet Therapy alone versus Lovenox plus Antiplatelet therapy in patients at increased risk of Stent Thrombosis (ATLAST) trialPeter B Berger, Ken W Mahaffey, Susan J Meier, et al.
American Journal of Nephrology|June 19, 2026
Adjudicating Heart Failure Events in Participants Receiving Hemodialysis: Findings from Evaluation of Cinacalcet Hydrochloride Therapy to Lower Cardiovascular Events (EVOLVE) TrialGuson Kang, Safa Abdalla, Patrick S Parfrey, et al.
Postgraduate Medicine|May 14, 2010
A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetesRobert Frederich, John H Alexander, Fred T Fiedorek, et al.
European Heart Journal|March 20, 2003
Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?A Hersi, Y Fu, B Wong, et al.
The Canadian Journal of Cardiology|April 28, 2006
N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarctionJustin A Ezekowitz, Pierre Théroux, Weiching Chang, et al.
Journal of Thrombosis and Thrombolysis|June 22, 2016
Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarctionSean van Diepen, Wendimagegn G Alemayehu, Yinggan Zheng, et al.
JACC. Cardiovascular Interventions|July 20, 2013
Prognostic significance of bleeding location and severity among patients with acute coronary syndromesJohn P Vavalle, Robert Clare, Karen Chiswell, et al.
American Heart Journal|January 25, 2008
Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapyDerek P Chew, Zhen Huang, Karen S Pieper, et al.
The Journal of Vascular Access|November 28, 2019
A double-blind, randomized, placebo-controlled pilot trial to evaluate safety and efficacy of vorapaxar on arteriovenous fistula maturationChristoph B Olivier, Vandana Sundaram, Glenn M Chertow, et al.
The American Journal of Cardiology|March 15, 1996
Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapyK W Mahaffey, C B Granger, R Collins, et al.
Pageof 63